LMP-1	B-protein
activates	O
NF-kappa	B-protein
B	I-protein
by	O
targeting	O
the	O
inhibitory	B-protein
molecule	I-protein
I	I-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

LMP-1	B-protein
,	O
an	O
Epstein-Barr	B-protein
virus	I-protein
membrane	I-protein
protein	I-protein
expressed	O
during	O
latent	O
infection	O
,	O
has	O
oncogenic	O
properties	O
,	O
as	O
judged	O
from	O
its	O
ability	O
to	O
transform	O
B	O
lymphocytes	B-cell_type
and	O
rodent	B-cell_type
fibroblasts	I-cell_type
.	O

LMP-1	B-protein
induces	O
the	O
expression	O
of	O
bcl2	B-DNA
,	O
an	O
oncogene	B-DNA
which	O
protects	O
cells	O
from	O
apoptosis	O
,	O
as	O
well	O
as	O
of	O
genes	O
encoding	O
other	O
proteins	O
involved	O
in	O
cell	O
regulation	O
and	O
growth	O
control	O
.	O

The	O
mechanisms	O
by	O
which	O
LMP-1	B-protein
upregulates	O
these	O
proteins	O
is	O
unknown	O
,	O
but	O
it	O
is	O
plausible	O
that	O
LMP-1	B-protein
modifies	O
signal	O
transduction	O
pathways	O
that	O
result	O
in	O
the	O
activation	O
of	O
one	O
or	O
more	O
transcription	B-protein
factors	I-protein
that	O
ultimately	O
regulate	O
transcription	O
of	O
oncogenic	B-DNA
genes	I-DNA
.	O

NF-kappa	B-protein
B	I-protein
,	O
a	O
transcription	B-protein
factor	I-protein
controlling	O
the	O
expression	O
of	O
genes	B-DNA
involved	O
in	O
cell	O
activation	O
and	O
growth	O
control	O
,	O
has	O
been	O
shown	O
to	O
be	O
activated	O
by	O
LMP-1	B-protein
.	O

The	O
mechanism	O
(	O
s	O
)	O
regulating	O
this	O
activation	O
remains	O
unknown	O
.	O

Our	O
data	O
indicate	O
that	O
increased	O
NF-kappa	B-protein
B	I-protein
DNA	O
binding	O
and	O
functional	O
activity	O
are	O
present	O
in	O
B-lymphoid	B-cell_type
cells	I-cell_type
stably	O
or	O
transiently	O
expressing	O
LMP-1	B-protein
.	O

I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
is	O
selectively	O
modified	O
in	O
LMP-1-expressing	B-cell_line
B	I-cell_line
cells	I-cell_line
.	O

A	O
phosphorylated	O
form	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
and	O
increased	O
protein	O
turnover-degradation	O
correlate	O
with	O
increased	O
NF-kappa	B-protein
B	I-protein
nuclear	O
translocation	O
.	O

This	O
results	O
in	O
increased	O
transcription	O
of	O
NF-kappa	B-DNA
B-dependent-genes	I-DNA
,	O
including	O
those	O
encoding	O
p105	B-protein
and	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
(	O
MAD3	B-DNA
)	O
.	O

These	O
results	O
indicate	O
that	O
LMP-1	B-protein
activates	O
NF-kappa	B-protein
B	I-protein
in	O
B-cell	B-cell_line
lines	I-cell_line
by	O
targeting	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

Identification	O
of	O
the	O
pathways	O
activated	O
by	O
LMP-1	B-protein
to	O
result	O
in	O
posttranslational	O
modifications	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
will	O
aid	O
in	O
determining	O
the	O
role	O
of	O
this	O
virus-host	O
cell	O
protein	O
interaction	O
in	O
Epstein-Barr	O
virus-mediated	O
oncogenesis	O
.	O

JournaL	NULL
or	NULL
VirRoLoGYy	NULL
,	NULL
Apr	NULL
.	NULL

1995	NULL
,	NULL
p.	NULL
2168-2174	NULL
0022-538	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

69	NULL
,	NULL
No	NULL
.	NULL

4	NULL
LMP-1	NULL
Activates	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
Targeting	NULL
the	NULL
Inhibitory	NULL
Molecule	NULL
IxBa	NULL
JOSE	NULL
A.	NULL
HERRERO	NULL
,	NULL
*	NULL
PAUL	NULL
MATHEW	NULL
,	NULL
**	NULL
anp	NULL
CARLOS	NULL
V.	NULL
PAYA*	NULL
``	NULL
``	NULL
*	NULL
Divisions	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
``	NULL
Infectious	NULL
Diseases	NULL
,	NULL
``	NULL
and	NULL
Hematology-Oncology	NULL
,	NULL
``	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
Minnesota	NULL
55905	NULL
Received	NULL
12	NULL
September	NULL
1994/Accepted	NULL
12	NULL
October	NULL
1994	NULL
LMP-1	NULL
,	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
membrane	NULL
protein	NULL
expressed	NULL
during	NULL
latent	NULL
infection	NULL
,	NULL
has	NULL
oncogenic	NULL
proper-ties	NULL
,	NULL
as	NULL
judged	NULL
from	NULL
its	NULL
ability	NULL
to	NULL
transform	NULL
B	NULL
lymphocytes	NULL
and	NULL
rodent	NULL
fibroblasts	NULL
.	NULL

LMP-1	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
be/2	NULL
,	NULL
an	NULL
oncogene	NULL
which	NULL
protects	NULL
cells	NULL
from	NULL
apoptosis	NULL
,	NULL
as	NULL
well	NULL
as	NULL
of	NULL
genes	NULL
encoding	NULL
other	NULL
proteins	NULL
involved	NULL
in	NULL
cell	NULL
regulation	NULL
and	NULL
growth	NULL
control	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
LMP-1	NULL
upregulates	NULL
these	NULL
proteins	NULL
is	NULL
unknown	NULL
,	NULL
but	NULL
it	NULL
is	NULL
plausible	NULL
that	NULL
LMP-1	NULL
modifies	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
transcription	NULL
factors	NULL
that	NULL
ultimately	NULL
regulate	NULL
transcription	NULL
of	NULL
oncogenic	NULL
genes	NULL
.	NULL

NF-KB	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
controlling	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
growth	NULL
control	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
LMP-1	NULL
.	NULL

The	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
regulating	NULL
this	NULL
activation	NULL
remains	NULL
unknown	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
increased	NULL
NF-B	NULL
DNA	NULL
binding	NULL
and	NULL
functional	NULL
activity	NULL
are	NULL
present	NULL
in	NULL
B-lymphoid	NULL
cells	NULL
stably	NULL
or	NULL
transiently	NULL
expressing	NULL
LMP-1	NULL
.	NULL

is	NULL
selectively	NULL
modified	NULL
in	NULL
LMP-l-expressing	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
and	NULL
increased	NULL
protein	NULL
turnover-degradation	NULL
correlate	NULL
with	NULL
increased	NULL
NF-KB	NULL
nuclear	NULL
translocation	NULL
.	NULL

This	NULL
results	NULL
in	NULL
increased	NULL
transcription	NULL
of	NULL
NF-B-dependent-genes	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
p105	NULL
and	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
LMP-1	NULL
activates	NULL
NF-KB	NULL
in	NULL
B-cell	NULL
lines	NULL
by	NULL
targeting	NULL
IBa	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
pathways	NULL
activated	NULL
by	NULL
LMP-1	NULL
to	NULL
result	NULL
in	NULL
posttranslational	NULL
modifications	NULL
of	NULL
IxBa	NULL
will	NULL
aid	NULL
in	NULL
determining	NULL
the	NULL
role	NULL
of	NULL
this	NULL
virus-host	NULL
cell	NULL
protein	NULL
interaction	NULL
in	NULL
Epstein-Barr	NULL
virus-mediated	NULL
oncogenesis	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
major	NULL
cause	NULL
of	NULL
infectious	NULL
mononucleosis	NULL
and	NULL
is	NULL
a	NULL
prototypic	NULL
oncogenic	NULL
virus	NULL
.	NULL

EBV	NULL
has	NULL
also	NULL
been	NULL
associated	NULL
with	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
B-cell	NULL
lymphomas	NULL
in	NULL
immunocompromised	NULL
individuals	NULL
,	NULL
notably	NULL
posttransplant	NULL
lymphoproliferative	NULL
disease	NULL
(	NULL
17	NULL
,	NULL
30	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
herpesvirus	NULL
family	NULL
,	NULL
EBV	NULL
can	NULL
remain	NULL
in	NULL
a	NULL
latent	NULL
state	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

During	NULL
latent	NULL
infection	NULL
,	NULL
different	NULL
EBV	NULL
proteins	NULL
,	NULL
including	NULL
six	NULL
nuclear	NULL
proteins	NULL
(	NULL
EBNAs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3A	NULL
,	NULL
3B	NULL
,	NULL
3C	NULL
,	NULL
and	NULL
LP	NULL
)	NULL
,	NULL
three	NULL
integral	NULL
membrane	NULL
proteins	NULL
(	NULL
LMP	NULL
-2A	NULL
,	NULL
and	NULL
-2B	NULL
)	NULL
,	NULL
and	NULL
two	NULL
small	NULL
RNAs	NULL
(	NULL
EBER1	NULL
and	NULL
-2	NULL
)	NULL
,	NULL
can	NULL
be	NULL
expressed	NULL
(	NULL
36	NULL
)	NULL
.	NULL

LMP-1	NULL
is	NULL
a	NULL
plasma	NULL
membrane	NULL
protein	NULL
containing	NULL
a	NULL
transmembrane	NULL
and	NULL
a	NULL
cytoplasmic	NULL
domain	NULL
which	NULL
forms	NULL
a	NULL
tight	NULL
patch	NULL
within	NULL
the	NULL
cytoplasmic	NULL
membrane	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Its	NULL
individual	NULL
role	NULL
in	NULL
promoting	NULL
cell	NULL
transformation	NULL
has	NULL
been	NULL
clearly	NULL
demonstrated	NULL
:	NULL
transfection	NULL
of	NULL
the	NULL
LMP-1	NULL
gene	NULL
is	NULL
sufficient	NULL
to	NULL
transform	NULL
rodent	NULL
fibroblasts	NULL
and	NULL
normal	NULL
human	NULL
B	NULL
lymphocytes	NULL
,	NULL
and	NULL
EBV	NULL
lacking	NULL
the	NULL
LMP-1	NULL
gene	NULL
does	NULL
not	NULL
transform	NULL
B	NULL
lymphocytes	NULL
(	NULL
19	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
mediating	NULL
LMP	NULL
-induced	NULL
oncogenesis	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Evidence	NULL
of	NULL
cell	NULL
activation	NULL
(	NULL
increase	NULL
in	NULL
CD23	NULL
and	NULL
CD40	NULL
receptors	NULL
)	NULL
and	NULL
upregulation	NULL
of	NULL
adhesion	NULL
molecules	NULL
(	NULL
LFA1I	NULL
,	NULL
LFA3	NULL
,	NULL
and	NULL
ICAM1	NULL
)	NULL
is	NULL
present	NULL
in	NULL
LMP-1-transfected	NULL
cells	NULL
,	NULL
reflecting	NULL
modulation	NULL
of	NULL
potential	NULL
oncogenic	NULL
mechanisms	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
although	NULL
the	NULL
issue	NULL
is	NULL
controversial	NULL
,	NULL
LMP-1	NULL
has	NULL
been	NULL
directly	NULL
associated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
proto-oncogenes	NULL
such	NULL
as	NULL
bel2	NULL
that	NULL
render	NULL
B	NULL
lymphocytes	NULL
resistant	NULL
to	NULL
apoptotic	NULL
death	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
28	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Whether	NULL
any	NULL
of	NULL
these	NULL
mechanisms	NULL
mediate	NULL
LMP-1-induced	NULL
oncogenesis	NULL
is	NULL
under	NULL
study	NULL
.	NULL

Other	NULL
viral	NULL
proteins	NULL
that	NULL
convey	NULL
transformation	NULL
phenotypes	NULL
,	NULL
such	NULL
as	NULL
bovine	NULL
papillomavirus	NULL
E5	NULL
,	NULL
are	NULL
similar	NULL
in	NULL
structure	NULL
and	NULL
membrane	NULL
localization	NULL
to	NULL
LMP-1	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
cytoplasmic	NULL
membrane-associated	NULL
growth	NULL
factor	NULL
receptors	NULL
(	NULL
32	NULL
)	NULL
.	NULL

LMP	NULL
-1	NULL
in	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
200	NULL
First	NULL
St.	NULL
SW	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
507	NULL
)	NULL
284-3747	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
507	NULL
)	NULL
284-3757	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
PAYA	NULL
@	NULL
MAYO.EDU	NULL
.	NULL

2168	NULL
teracts	NULL
with	NULL
vimentin	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
known	NULL
if	NULL
it	NULL
interacts	NULL
with	NULL
other	NULL
membrane-associated	NULL
molecules	NULL
that	NULL
potentially	NULL
regulate	NULL
oncogenesis	NULL
(	NULL
24	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
plausible	NULL
that	NULL
LMP-1	NULL
results	NULL
in	NULL
the	NULL
modification	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
ultimately	NULL
regulate	NULL
specific	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
gene	NULL
regulation	NULL
and	NULL
oncogenesis	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
NF-kB	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
shown	NULL
to	NULL
regulate	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
growth	NULL
control	NULL
and	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
different	NULL
viral	NULL
proteins	NULL
with	NULL
oncogenic	NULL
potential	NULL
such	NULL
as	NULL
hepatitis	NULL
B	NULL
virus	NULL
HBX	NULL
protein	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
Tax	NULL
(	NULL
16	NULL
,	NULL
27	NULL
)	NULL
.	NULL

NF-kB	NULL
belongs	NULL
to	NULL
a	NULL
highly	NULL
conserved	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
with	NULL
N-terminal	NULL
homology	NULL
to	NULL
the	NULL
v-rel	NULL
oncogene	NULL
(	NULL
implicated	NULL
in	NULL
avian	NULL
lymphoblastoid	NULL
tumor	NULL
pro-duction	NULL
)	NULL
(	NULL
23	NULL
)	NULL
that	NULL
includes	NULL
c-re/	NULL
,	NULL
p50	NULL
(	NULL
NF-kB1	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
NF-kB2	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
relA	NULL
)	NULL
,	NULL
relB	NULL
,	NULL
and	NULL
dorsal	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
3	NULL
and	NULL
31	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
polypeptides	NULL
can	NULL
form	NULL
homodimers	NULL
or	NULL
dimerize	NULL
with	NULL
other	NULL
Rel	NULL
family	NULL
members	NULL
,	NULL
although	NULL
the	NULL
prototype	NULL
NF-kB	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

The	NULL
function	NULL
of	NULL
NF-KB	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
series	NULL
of	NULL
inhibitory	NULL
molecules	NULL
named	NULL
IxBs	NULL
.	NULL

The	NULL
family	NULL
of	NULL
IxB	NULL
molecules	NULL
includes	NULL
IxBa	NULL
,	NULL
IBB	NULL
,	NULL
IxBy	NULL
,	NULL
p105	NULL
,	NULL
and	NULL
p100	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
31	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
two	NULL
molecules	NULL
are	NULL
also	NULL
the	NULL
precursors	NULL
of	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
respectively	NULL
(	NULL
20	NULL
,	NULL
35	NULL
)	NULL
.	NULL

IxB	NULL
molecules	NULL
function	NULL
by	NULL
sequestering	NULL
NF-KB	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
rendering	NULL
it	NULL
inactive	NULL
(	NULL
2	NULL
,	NULL
31	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
different	NULL
IxBs	NULL
,	NULL
IxBa	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Posttranslational	NULL
modifications	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
different	NULL
stimuli	NULL
and/or	NULL
viral	NULL
infection	NULL
that	NULL
activate	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
include	NULL
its	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
proteolytic	NULL
degradation	NULL
.	NULL

This	NULL
causes	NULL
the	NULL
release	NULL
of	NULL
NF-KB	NULL
,	NULL
which	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
29	NULL
,	NULL
31	NULL
,	NULL
33	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
gene	NULL
is	NULL
NF-kB	NULL
dependent	NULL
(	NULL
22	NULL
)	NULL
,	NULL
translocation	NULL
of	NULL
NF-kB	NULL
secondary	NULL
to	NULL
IxBa	NULL
proteolysis	NULL
will	NULL
upregulate	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
to	NULL
resynthesize	NULL
and	NULL
replenish	NULL
the	NULL
cytosolic	NULL
IxBa	NULL
pool	NULL
,	NULL
thus	NULL
interrupting	NULL
the	NULL
cycle	NULL
of	NULL
activation	NULL
by	NULL
anchoring	NULL
p65	NULL
and	NULL
p50	NULL
in	NULL
the	NULL
cytosol	NULL
(	NULL
22	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
whether	NULL
and	NULL
through	NULL
which	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
mechanisms	NULL
NF-KB	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
oncogenic	NULL
EBV	NULL
protein	NULL
LMP	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

To	NULL
do	NULL
so	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
variety	NULL
of	NULL
B-cell	NULL
lines	NULL
which	NULL
stably	NULL
express	NULL
LMP-1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
models	NULL
of	NULL
transient	NULL
LMP-1	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
LMP-1	NULL
activates	NULL
NF-kB	NULL
in	NULL
B	NULL
lymphocytes	NULL
by	NULL
targeting	NULL
the	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

Jurkat	NULL
T-cell	NULL
lines	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
B-cell	NULL
line	NULL
Ly1	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
D.	NULL
Jelinek	NULL
,	NULL
Mayo	NULL
Clinic	NULL
.	NULL

The	NULL
parental	NULL
cell	NULL
line	NULL
BJAB	NULL
is	NULL
an	NULL
EBV-negative	NULL
African	NULL
Burkitt	NULL
's	NULL
lymphoma-derived	NULL
cell	NULL
line	NULL
.	NULL

BJB3LT	NULL
is	NULL
a	NULL
BJAB	NULL
cell	NULL
line	NULL
stably	NULL
expressing	NULL
the	NULL
LMP-1	NULL
gene	NULL
;	NULL
both	NULL
cell	NULL
lines	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Georg	NULL
Klein	NULL
(	NULL
Karolinska	NULL
Institute	NULL
,	NULL
Stockholm	NULL
,	NULL
Sweden	NULL
)	NULL
(	NULL
8	NULL
)	NULL
.	NULL

BJgp2	NULL
is	NULL
a	NULL
BJAB	NULL
cell	NULL
line	NULL
stably	NULL
expressing	NULL
plasmid	NULL
MTLM	NULL
gpt-LMP-1	NULL
,	NULL
while	NULL
its	NULL
control	NULL
cell	NULL
line	NULL
BJMTLM	NULL
is	NULL
the	NULL
BJAB	NULL
cell	NULL
line	NULL
stably	NULL
transfected	NULL
with	NULL
plasmid	NULL
MTLM	NULL
gpt	NULL
.	NULL

BL41	NULL
is	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
EBV-negative	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
BLgpt1	NULL
cells	NULL
are	NULL
BL41	NULL
cells	NULL
stably	NULL
expressing	NULL
LMP-1	NULL
.	NULL

The	NULL
two	NULL
latter	NULL
sets	NULL
of	NULL
cell	NULL
lines	NULL
were	NULL
provided	NULL
by	NULL
Fred	NULL
Wang	NULL
(	NULL
Harvard	NULL
University	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
specified	NULL
above	NULL
were	NULL
found	NULL
to	NULL
be	NULL
negative	NULL
for	NULL
Mycoplasma	NULL
infection	NULL
upon	NULL
repetitive	NULL
testing	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
200	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
200	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
and	NULL
passaged	NULL
at	NULL
an	NULL
initial	NULL
concentration	NULL
of	NULL
0.1	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
every	NULL
3.5	NULL
days	NULL
.	NULL

BJMTLM	NULL
,	NULL
BJgpt2	NULL
,	NULL
BL41	NULL
,	NULL
and	NULL
Bl41-gptl	NULL
cells	NULL
were	NULL
passaged	NULL
in	NULL
the	NULL
above-described	NULL
culture	NULL
medium	NULL
supplemented	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
mycophenolic	NULL
acid	NULL
(	NULL
Gibco-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

and	NULL
xanthine-hypoxanthine	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

For	NULL
ex-periments	NULL
,	NULL
cells	NULL
were	NULL
passaged	NULL
at	NULL
0.2	NULL
x	NULL
10°	NULL
to	NULL
0.3	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
used	NULL
48	NULL
h	NULL
later	NULL
.	NULL

BJB3LT	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
be	NULL
refractory	NULL
to	NULL
serum	NULL
deprivation-induced	NULL
apoptosis	NULL
.	NULL

LMP-1	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
immunofluorescence	NULL
and	NULL
immunoprecipitation	NULL
using	NULL
CS1-4	NULL
antibodies	NULL
(	NULL
Dako	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Plasmids	NULL
and	NULL
plasmid	NULL
construction	NULL
.	NULL

The	NULL
«	NULL
B-conalbumin-luciferase	NULL
(	NULL
«	NULL
B-c-luc	NULL
)	NULL
plasmid	NULL
contains	NULL
three	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
xB	NULL
motif	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
long	NULL
terminal	NULL
repeats	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
conalbumin	NULL
promoter	NULL
and	NULL
luciferase	NULL
gene	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
-B-galactosidase	NULL
B-Gal	NULL
plasmid	NULL
is	NULL
a	NULL
reporter	NULL
vector	NULL
designed	NULL
for	NULL
expression	NULL
of	NULL
B-Gal	NULL
in	NULL
mammalian	NULL
cells	NULL
driven	NULL
by	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
TK	NULL
minimal	NULL
promoter	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
LMP-1	NULL
gene	NULL
inserted	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pUC19	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Fred	NULL
Wang	NULL
and	NULL
Elliott	NULL
Kieff	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL

(	NULL
42	NULL
)	NULL
and	NULL
cloned	NULL
by	NULL
using	NULL
the	NULL
BamHI	NULL
site	NULL
into	NULL
peDNA3	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
yielding	NULL
peDNA3-LMP-1	NULL
.	NULL

An	NULL
antisense	NULL
LMP-1	NULL
cloned	NULL
in	NULL
the	NULL
same	NULL
vector	NULL
(	NULL
peDNA-1PML	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

MAD3	NULL
luc	NULL
,	NULL
MAD3	NULL
AxB-luc	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
p105**	NULL
(	NULL
40	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Plasmids	NULL
were	NULL
amplified	NULL
in	NULL
Escherichia	NULL
coli	NULL
DHS	NULL
«	NULL
and	NULL
purified	NULL
by	NULL
using	NULL
commercial	NULL
kits	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Electroporation	NULL
.	NULL

Cell	NULL
were	NULL
electroporated	NULL
in	NULL
disposable	NULL
sterilized	NULL
cuvettes	NULL
(	NULL
PG220D	NULL
;	NULL
Hoefer	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
using	NULL
the	NULL
Progenetor	NULL
II	NULL
electroporator	NULL
(	NULL
Hoefer	NULL
Scientific	NULL
Instruments	NULL
)	NULL
with	NULL
the	NULL
following	NULL
settings	NULL
:	NULL
300	NULL
V	NULL
,	NULL
980	NULL
mF	NULL
,	NULL
and	NULL
1	NULL
s	NULL
of	NULL
discharge	NULL
duration	NULL
.	NULL

Cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
during	NULL
10	NULL
min	NULL
with	NULL
3	NULL
mg	NULL
of	NULL
B-Luc	NULL
or	NULL
5	NULL
pg	NULL
of	NULL
AP1-Luc	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
TK-B-Gal	NULL
as	NULL
reporter	NULL
plasmids	NULL
and	NULL
variable	NULL
amounts	NULL
(	NULL
as	NULL
indicated	NULL
in	NULL
Results	NULL
)	NULL
of	NULL
peDNA3-LMP-1	NULL
or	NULL
peDNA3-1PML	NULL
in	NULL
0.8	NULL
ml	NULL
of	NULL
serum-free	NULL
RPMI	NULL
medium	NULL
.	NULL

Following	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
10	NULL
ml	NULL
of	NULL
RPMI-10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
medium	NULL
and	NULL
harvested	NULL
between	NULL
16	NULL
and	NULL
24	NULL
h	NULL
after	NULL
electroporation	NULL
,	NULL
using	NULL
125	NULL
pl	NULL
of	NULL
cell	NULL
culture	NULL
lysis	NULL
reagent	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

Luciferase	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
100	NULL
pl	NULL
by	NULL
using	NULL
the	NULL
Promega	NULL
luciferase	NULL
assay	NULL
system	NULL
,	NULL
and	NULL
B-Gal	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
15	NULL
ul	NULL
by	NULL
using	NULL
the	NULL
Tropix	NULL
Galacto-Light	NULL
reporter	NULL
assay	NULL
(	NULL
Tropix	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Both	NULL
luciferase	NULL
and	NULL
B-Gal	NULL
were	NULL
measured	NULL
in	NULL
a	NULL
Berthold	NULL
luminometer	NULL
.	NULL

Total	NULL
protein	NULL
in	NULL
an	NULL
aliquot	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
technique	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
represented	NULL
as	NULL
luciferase	NULL
units	NULL
per	NULL
B-Gal	NULL
unit	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
four	NULL
different	NULL
sets	NULL
of	NULL
experiments	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
EMSA	NULL
.	NULL

Cytosolic	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
extracted	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
20	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpipera-zine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
20	NULL
mg	NULL
of	NULL
Pefabloc	NULL
per	NULL
ml	NULL
)	NULL
to	NULL
which	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
20	NULL
to	NULL
30	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
Pefabloc	NULL
)	NULL
,	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
centrifugated	NULL
.	NULL

Fifty	NULL
microliters	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
20	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
glycerol	NULL
,	NULL
0.05	NULL
M	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
Pefabloc	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
supernatant	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
3	NULL
to	NULL
4	NULL
jg	NULL
of	NULL
nuclear	NULL
protein	NULL
,	NULL
incubating	NULL
the	NULL
protein	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
1	NULL
mg	NULL
of	NULL
sonicated	NULL
single-stranded	NULL
DNA	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
N.J.	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
15	NULL
to	NULL
20	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Then	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
with	NULL
antibody	NULL
or	NULL
nonla-beled	NULL
oligonucleotide	NULL
and	NULL
with	NULL
70,000	NULL
to	NULL
100,000	NULL
cpm	NULL
of	NULL
[	NULL
y-	NULL
>	NULL
PJATP-labeled	NULL
double-stranded	NULL
oligodeoxynucleotide	NULL
probe	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
product	NULL
of	NULL
this	NULL
reaction	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
nondenaturing	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

DNA	NULL
binding	NULL
com	NULL
NF-kB	NULL
ACTIVATION	NULL
BY	NULL
LMP-1	NULL
2169	NULL
petition	NULL
was	NULL
assessed	NULL
by	NULL
preincubating	NULL
the	NULL
nuclear	NULL
extract	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
for	NULL
5	NULL
min	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
anti-NF-	NULL
«	NULL
B	NULL
antibodies	NULL
(	NULL
anti-p65	NULL
,	NULL
anti-p50	NULL
,	NULL
anti-p52	NULL
,	NULL
and	NULL
anti-c-Rel	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
was	NULL
added	NULL
to	NULL
supershift	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
EMSA	NULL
corresponded	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
present	NULL
within	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
5'-ACAAGGGACTTTCCGCTGG	NULL
GGACTTTCCAGGGA-3	NULL
'	NULL
)	NULL
,	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
AP1	NULL
(	NULL
5-CGCTTG	NULL
ATGAGTCAGCCGGAA-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
CREB	NULL
(	NULL
5'-AGAGATTGCCTGACGTCAG	NULL
AGAGCTAG-3	NULL
'	NULL
)	NULL
.	NULL

Western	NULL
blots	NULL
(	NULL
immunoblots	NULL
)	NULL
.	NULL

Cytosolic	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
the	NULL
same	NULL
procedure	NULL
as	NULL
nuclear	NULL
extracts	NULL
after	NULL
lysing	NULL
the	NULL
cells	NULL
with	NULL
buffer	NULL
A	NULL
with	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
resultant	NULL
supernatant	NULL
contained	NULL
cytosolic	NULL
proteins	NULL
.	NULL

Proteins	NULL
(	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-10	NULL
to	NULL
12.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

Immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
commercially	NULL
available	NULL
anti-p65	NULL
,	NULL
p50	NULL
,	NULL
p100	NULL
,	NULL
and	NULL
c-Rel	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
and	NULL
visualized	NULL
by	NULL
using	NULL
an	NULL
ECL	NULL
(	NULL
enhanced	NULL
chemilumines-cence	NULL
)	NULL
Western	NULL
blotting	NULL
detection	NULL
kit	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
III	NULL
.	NULL
)	NULL

.	NULL

RNA	NULL
extraction	NULL
and	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
in	NULL
an	NULL
agarose-formamide	NULL
0.9	NULL
%	NULL
gel	NULL
(	NULL
2	NULL
h	NULL
,	NULL
60	NULL
V	NULL
)	NULL
,	NULL
transferred	NULL
overnight	NULL
to	NULL
a	NULL
Hybond-N+	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
by	NULL
osmosis	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
*°P-labeled	NULL
probes	NULL
.	NULL

The	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
probe	NULL
consisted	NULL
of	NULL
a	NULL
1.3-kb	NULL
EcoRI-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
MAD3	NULL
cDNA	NULL
,	NULL
the	NULL
p105	NULL
probe	NULL
is	NULL
a	NULL
1.9-kb	NULL
Psfl	NULL
fragment	NULL
,	NULL
and	NULL
the	NULL
GAPDH	NULL
probe	NULL
is	NULL
a	NULL
1.3-kb	NULL
Psfl	NULL
fragment	NULL
.	NULL

Probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a	NULL
«	NULL
-P	NULL
]	NULL
JdCTP	NULL
by	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
Ind	NULL
.	NULL
)	NULL

.	NULL

[	NULL
*°S	NULL
]	NULL
methionine-cysteine	NULL
labeling	NULL
,	NULL
chase	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
.	NULL

Cells	NULL
(	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
per	NULL
point	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
were	NULL
incubated	NULL
in	NULL
preconditioned	NULL
methionine-	NULL
and	NULL
cysteine-free	NULL
medium	NULL
(	NULL
ICN	NULL
,	NULL
Irvine	NULL
,	NULL
Calif.	NULL
)	NULL
for	NULL
4	NULL
h	NULL
in	NULL
T25	NULL
flasks	NULL
and	NULL
then	NULL
labeled	NULL
with	NULL
0.5	NULL
mCi	NULL
of	NULL
*°S-labeled	NULL
methionine	NULL
and	NULL
cysteine	NULL
(	NULL
Translabel	NULL
;	NULL
ICN	NULL
)	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
culture	NULL
supernatant	NULL
was	NULL
aspirated	NULL
,	NULL
and	NULL
10	NULL
ml	NULL
of	NULL
regular	NULL
medium	NULL
supplemented	NULL
with	NULL
L-methionine	NULL
and	NULL
L-cysteine	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
in	NULL
this	NULL
medium	NULL
for	NULL
different	NULL
lengths	NULL
of	NULL
time	NULL
and	NULL
harvested	NULL
by	NULL
using	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mg	NULL
of	NULL
p-nitrophenyl	NULL
phosphate	NULL
per	NULL
ml	NULL
,	NULL
30	NULL
mM	NULL
pyrophosphate	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
B-glycerolphosphate	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
mg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
mg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
anti-IxBo	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Protein	NULL
G-agarose	NULL
beads	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
were	NULL
added	NULL
to	NULL
cach	NULL
sample	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
washed	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
was	NULL
eluted	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

These	NULL
cluants	NULL
were	NULL
separated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
transferred	NULL
to	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
as	NULL
described	NULL
above	NULL
for	NULL
Western	NULL
blots	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
calf	NULL
intestinal	NULL
phosphatase	NULL
(	NULL
CIP	NULL
)	NULL
treatment	NULL
,	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
[	NULL
**S	NULL
)	NULL
Jme-thionine-cysteine	NULL
labeled	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
treated	NULL
with	NULL
33	NULL
U	NULL
of	NULL
CIP	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

or	NULL
mock	NULL
treated	NULL
in	NULL
50	NULL
jl	NULL
of	NULL
50	NULL
mM	NULL
Tris	NULL
HCI	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
-1	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
at	NULL
32°C	NULL
for	NULL
15	NULL
min	NULL
,	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Transient	NULL
expression	NULL
of	NULL
LMP-1	NULL
increases	NULL
NF-KB	NULL
activity	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
whether	NULL
transient	NULL
LMP-1	NULL
expression	NULL
in	NULL
the	NULL
EBV-negative	NULL
cell	NULL
lines	NULL
BJAB	NULL
,	NULL
Ly1	NULL
,	NULL
and	NULL
Jurkat	NULL
resulted	NULL
in	NULL
NF-KB	NULL
activation	NULL
.	NULL

pcDNA-LMP-1	NULL
or	NULL
its	NULL
antisense	NULL
control	NULL
were	NULL
separately	NULL
cotransfected	NULL
with	NULL
the	NULL
«	NULL
B-c-lue	NULL
construct	NULL
and	NULL
a	NULL
TK-B-Gal	NULL
reporter	NULL
to	NULL
normalize	NULL
transfection	NULL
efficiency	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
LMP	NULL
increases	NULL
the	NULL
luciferase	NULL
expression	NULL
driven	NULL
by	NULL
the	NULL
kB	NULL
concatemer	NULL
,	NULL
while	NULL
the	NULL
control	NULL
plasmid	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
basal	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
activity	NULL
.	NULL

Neither	NULL
LMP-1	NULL
or	NULL
its	NULL
antisense	NULL
control	NULL
plasmid	NULL
modified	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
AP1-c-luc	NULL
construct	NULL
or	NULL
of	NULL
the	NULL
minimal	NULL
conalbumin	NULL
promoter-luciferase	NULL
gene	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
LMP-1	NULL
increases	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
we	NULL
next	NULL
determined	NULL
whether	NULL
transient	NULL
expression	NULL
of	NULL
this	NULL
viral	NULL
protein	NULL
increases	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

For	NULL
this	NULL
,	NULL
LMP	NULL
or	NULL
its	NULL
antisense	NULL
control	NULL
plasmid	NULL
was	NULL
electroporated	NULL
into	NULL
BJAB	NULL
cells	NULL
.	NULL

Eighteen	NULL
hours	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
isolated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
transfection	NULL
of	NULL
an	NULL
antisense	NULL
LMP-1	NULL
plasmid	NULL
does	NULL
not	NULL
modify	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
while	NULL
increased	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
is	NULL
present	NULL
in	NULL
LMP-1	NULL
gene-transfected	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
complex	NULL
binding	NULL
DNA	NULL
is	NULL
specifically	NULL
competed	NULL
for	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-KB	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

No	NULL
increased	NULL
DNA	NULL
binding	NULL
was	NULL
observed	NULL
in	NULL
2170	NULL
HERRERO	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

A	NULL
wo	NULL
P	NULL
is	NULL
35	NULL
9	NULL
60	NULL
©	NULL
8	NULL
A	NULL
re	NULL
p	NULL
30	NULL
50	NULL
<	NULL
5	NULL
»	NULL
68	NULL
$	NULL
8	NULL
_	NULL
,	NULL
25	NULL
7	NULL
6	NULL
40	NULL
8	NULL
\	NULL
&	NULL
v	NULL
-	NULL
NFkB	NULL
c	NULL
5	NULL
3	NULL
30	NULL
9	NULL
-	NULL
15	NULL
4	NULL
3	NULL
20	NULL
2	NULL
49	NULL
o	NULL
3	NULL
2	NULL
5	NULL
10	NULL
1	NULL
|	NULL
|	NULL
0	NULL
L_	NULL
]	NULL
0	NULL
[	NULL
]	NULL
T	NULL
0	NULL
T	NULL
T	NULL
j	NULL
T	NULL
T	NULL
1	NULL
LMP1	NULL
|LMP1	NULL
LMP1	NULL
LMP1	NULL
LMP1	NULL
%	NULL
t	NULL
EFFECTOR	NULL
PLASMID	NULL
|	NULL
-	NULL
spm	NULL
8	NULL
)	NULL
|	NULL
ao	NULL
|	NULL
!	NULL

PM4P	NULL
ao	NULL
1PML	NULL
(	NULL
10	NULL
)	NULL
1PML	NULL
(	NULL
10	NULL
)	NULL
LUC	NULL
PLASMID	NULL
kB	NULL
[	NULL
kB	NULL
[	NULL
kB	NULL
jaPi	NULL
[	NULL
AP1	NULL
kB	NULL
kB	NULL
kB	NULL
kB	NULL
CELL	NULL
LINE	NULL
BJAB	NULL
Ly1	NULL
JURKAT	NULL
-	NULL
Free	NULL
probe	NULL
1	NULL
2	NULL
3	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
LMP-1	NULL
increases	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cotransfection	NULL
of	NULL
10	NULL
``	NULL
BJAB	NULL
,	NULL
Ly1	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
with	NULL
pcDNA3-1PML	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
and	NULL
5	NULL
or	NULL
10	NULL
g	NULL
of	NULL
pecDNA3-LMP-1	NULL
and	NULL
a	NULL
«	NULL
B-c-luc	NULL
or	NULL
AP1-c-luc	NULL
reporter	NULL
gene	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
in	NULL
luciferase	NULL
(	NULL
LUC	NULL
)	NULL
light	NULL
units	NULL
normalized	NULL
to	NULL
B-Gal	NULL
units	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
BJAB	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pcDNA3-1PML	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
pcDNA3	NULL
LMP-1	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
nuclear	NULL
protein	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
free	NULL
probe	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
right	NULL
.	NULL

nuclear	NULL
fractions	NULL
from	NULL
LMP	NULL
or	NULL
control	NULL
transfected	NULL
cells	NULL
when	NULL
a	NULL
labeled	NULL
AP1	NULL
oligonucleotide	NULL
was	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
transient	NULL
expression	NULL
of	NULL
the	NULL
EBV	NULL
LMP-1	NULL
protein	NULL
results	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

NF-KB	NULL
activation	NULL
is	NULL
increased	NULL
in	NULL
B-cell	NULL
lines	NULL
stably	NULL
expressing	NULL
LMP-1	NULL
.	NULL

To	NULL
further	NULL
study	NULL
in	NULL
detail	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
LMP	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
we	NULL
used	NULL
three	NULL
B-cell	NULL
lines	NULL
that	NULL
stably	NULL
express	NULL
this	NULL
viral	NULL
protein	NULL
:	NULL
BJB3LT	NULL
,	NULL
BJgpt2	NULL
,	NULL
and	NULL
Blgptl	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
greater	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
LMP-1-positive	NULL
(	NULL
BJB3LT	NULL
,	NULL
BJgpt2	NULL
,	NULL
and	NULL
BlLgptl	NULL
)	NULL
than	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
parental	NULL
LMP-1-negative	NULL
cell	NULL
lines	NULL
(	NULL
BJAB	NULL
,	NULL
BJMTLM	NULL
,	NULL
and	NULL
BLA1	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
was	NULL
greater	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
LMP-1-positive	NULL
cells	NULL
than	NULL
in	NULL
their	NULL
respective	NULL
LMP-1-negative	NULL
controls	NULL
.	NULL

The	NULL
basal	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
present	NULL
in	NULL
BJAB	NULL
cells	NULL
increases	NULL
following	NULL
cell	NULL
stimulation	NULL
with	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
and	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
increased	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
BJB3LT	NULL
cells	NULL
is	NULL
specific	NULL
to	NULL
NF-kB	NULL
,	NULL
binding	NULL
to	NULL
AP1	NULL
and	NULL
CREB	NULL
motifs	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
of	NULL
BJAB	NULL
and	NULL
BjB3LT	NULL
cells	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
corresponding	NULL
labeled	NULL
oligonucleotides	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
no	NULL
significant	NULL
increase	NULL
in	NULL
AP1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
,	NULL
but	NULL
a	NULL
mild	NULL
increase	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
CREB	NULL
motif	NULL
was	NULL
found	NULL
.	NULL

Each	NULL
protein-DNA	NULL
complex	NULL
was	NULL
competed	NULL
for	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
corresponding	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
confirm	NULL
those	NULL
obtained	NULL
by	NULL
transiently	NULL
expressing	NULL
LMP	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
LMP-1	NULL
activates	NULL
NF-kB	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
increased	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
present	NULL
in	NULL
BJB3LT	NULL
cells	NULL
correlates	NULL
with	NULL
increased	NULL
NF-B-dependent	NULL
transcriptional	NULL
function	NULL
,	NULL
the	NULL
<	NULL
B-c-lue	NULL
reporter	NULL
gene	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
TK-B-Gal	NULL
reporter	NULL
gene	NULL
into	NULL
LMP	NULL
and	NULL
LMP-l-negative	NULL
cell	NULL
lines	NULL
.	NULL

Once	NULL
more	NULL
,	NULL
greater	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
LMP-1-positive	NULL
B	NULL
cells	NULL
(	NULL
BJB3LT	NULL
,	NULL
BLgpt1	NULL
,	NULL
and	NULL
BJgpt2	NULL
)	NULL
than	NULL
in	NULL
LMP-1-negative	NULL
parental	NULL
cells	NULL
(	NULL
BJAB	NULL
,	NULL
BL41	NULL
,	NULL
and	NULL
BJMTLM	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
transcriptional	NULL
activities	NULL
of	NULL
the	NULL
minimal	NULL
conal-	NULL
A	NULL
LABELED	NULL
olico	NULL
NF-kB	NULL
APi	NULL
ches	NULL
CELL	NULL
LINE	NULL
BJAB	NULL
BiBsLT	NULL
|BJAB	NULL
peal	NULL
?	NULL

|BJAB	NULL
|BieaLt	NULL
COMPETITION	NULL
-	NULL
l+	NULL
I-	NULL
,	NULL
+	NULL
-	NULL
[	NULL
+l-	NULL
l+	NULL
-l+	NULL
,	NULL
-	NULL
|+	NULL
'	NULL
wite	NULL
LABELED	NULL
olieo	NULL
NF-kB	NULL
NF-KB	NULL
CELL	NULL
LINE	NULL
BL41	NULL
|BL-gpti	NULL
||	NULL
BJ-MT	NULL
|	NULL
BJ-gpt2	NULL
COMPETITION	NULL
-	NULL
~	NULL
[	NULL
-|-B	NULL
200	NULL
140	NULL
-	NULL
160	NULL
PA	NULL
p	NULL
©	NULL
4	NULL
3	NULL
1004	NULL
€	NULL
8	NULL
100	NULL
@	NULL
Q	NULL
)	NULL
&	NULL
7	NULL
2-	NULL
100	NULL
{	NULL
3	NULL
E	NULL
4	NULL
$	NULL
$	NULL
E	NULL
3	NULL
a°	NULL
40	NULL
2	NULL
0	NULL
4	NULL
8	NULL
]	NULL
I	NULL
0	NULL
BJAB	NULL
BiBSLT	NULL
BL41-	NULL
Bigpn	NULL
-	NULL
'	NULL
'=	NULL
BMT	NULL
Bugpe	NULL
-	NULL
'	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

NF-xB	NULL
activation	NULL
is	NULL
increased	NULL
in	NULL
B-cell	NULL
lines	NULL
stably	NULL
expressing	NULL
LMP-1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
using	NULL
labeled	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP1	NULL
,	NULL
and	NULL
CREB	NULL
oligonucleotides	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJAB	NULL
and	NULL
BJB3LT	NULL
cells	NULL
or	NULL
labeled	NULL
NFB	NULL
oligonucleotides	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
BL41	NULL
,	NULL
BLgpt1	NULL
,	NULL
BIMTLM	NULL
,	NULL
and	NULL
BJgpt2	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfection	NULL
of	NULL
10	NULL
BJAB	NULL
,	NULL
BjB3LT	NULL
cells	NULL
,	NULL
BL41	NULL
,	NULL
BLgpt1	NULL
,	NULL
BIMTLM	NULL
,	NULL
and	NULL
BJgpt2	NULL
cells	NULL
with	NULL
B-c-luc	NULL
.	NULL

Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
cell	NULL
line	NULL
BJAB	NULL
competition	NULL
anti	NULL
p50	NULL
anti	NULL
p65	NULL
anti	NULL
p52	NULL
anti	NULL
c-re	NULL
!	NULL

BiB3LT	NULL
Cytosol	NULL
\	NULL
Nuclei	NULL
CytosolI	NULL
Nuclei	NULL
p105-	NULL
dik	NULL
.	NULL

wow	NULL
p100-	NULL
Game	NULL
l	NULL
=	NULL
MR	NULL
&	NULL
=	NULL
am	NULL
wae	NULL
.	NULL

p50-	NULL
-	NULL
'	NULL
yo	NULL
»	NULL
.	NULL

pS2-	NULL
eel	NULL
fual	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJAB	NULL
and	NULL
BJB3LT	NULL
cells	NULL
,	NULL
using	NULL
a	NULL
*°P-labeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
unlabeled	NULL
nucleotide	NULL
or	NULL
antibodies	NULL
against	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
or	NULL
c-Rel	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
p65-p50	NULL
,	NULL
p65-p52	NULL
and	NULL
p50-p50	NULL
complexes	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
from	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
of	NULL
BJAB	NULL
and	NULL
BJB3LT	NULL
cells	NULL
followed	NULL
by	NULL
immunoblotting	NULL
.	NULL

Signals	NULL
corresponding	NULL
to	NULL
p65	NULL
,	NULL
p105	NULL
,	NULL
p50	NULL
,	NULL
p100	NULL
,	NULL
and	NULL
p52	NULL
are	NULL
marked	NULL
at	NULL
the	NULL
left	NULL
.	NULL

Cytosol	NULL
|	NULL
Nuclei	NULL
BJAB	NULL
BiB3LT	NULL
BJAB	NULL
BiB3LT	NULL
BJAB	NULL
BiBSLT	NULL
BJAB	NULL
BiBSLT	NULL
BJAB	NULL
BiB3LT	NULL
BJAB	NULL
BiBSLT	NULL
pés-	NULL
wets	NULL
e	NULL
0	NULL
bumin	NULL
promoter-luciferase	NULL
and	NULL
AP1-conalbumin-luciferase	NULL
reporter	NULL
genes	NULL
were	NULL
similar	NULL
in	NULL
the	NULL
two	NULL
types	NULL
of	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
forms	NULL
of	NULL
NF-KB	NULL
activated	NULL
by	NULL
LMP-1	NULL
include	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p52	NULL
.	NULL

In	NULL
different	NULL
combinations	NULL
among	NULL
proteins	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
homo-	NULL
and	NULL
heterodimers	NULL
are	NULL
formed	NULL
,	NULL
each	NULL
of	NULL
which	NULL
is	NULL
regulated	NULL
by	NULL
specific	NULL
IxB	NULL
molecules	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
3	NULL
and	NULL
31	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
mechanisms	NULL
regulating	NULL
LMP-1-mediated	NULL
NF-kB	NULL
activation	NULL
,	NULL
we	NULL
first	NULL
determined	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
NF-kB-like	NULL
complex	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
BJB3LT	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
these	NULL
cells	NULL
and	NULL
of	NULL
control	NULL
BJAB	NULL
cells	NULL
were	NULL
analyzed	NULL
in	NULL
EMSA	NULL
using	NULL
specific	NULL
commercial	NULL
antibodies	NULL
to	NULL
the	NULL
different	NULL
Rel	NULL
protein	NULL
members	NULL
.	NULL

Using	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
NF-kB	NULL
binding	NULL
motif	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
DNA-binding	NULL
complexes	NULL
include	NULL
p65/pS50	NULL
and	NULL
p52	NULL
but	NULL
not	NULL
c-Rel	NULL
.	NULL

Antibodies	NULL
to	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p52	NULL
resulted	NULL
in	NULL
supershifts	NULL
of	NULL
the	NULL
DNA-binding	NULL
protein	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
anti-c-Rel	NULL
antibodies	NULL
were	NULL
used	NULL
.	NULL

We	NULL
next	NULL
confirmed	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
complex	NULL
by	NULL
analyzing	NULL
the	NULL
steady-state	NULL
protein	NULL
levels	NULL
of	NULL
the	NULL
different	NULL
NF-kB	NULL
subunits	NULL
in	NULL
both	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
frac-tions	NULL
,	NULL
using	NULL
Western	NULL
immunoblotting	NULL
techniques	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

p65	NULL
protein	NULL
levels	NULL
were	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
of	NULL
BJB3LT	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
that	NULL
of	NULL
the	NULL
control	NULL
BJAB	NULL
cells	NULL
,	NULL
suggesting	NULL
continuous	NULL
p65	NULL
nuclear	NULL
translocation	NULL
in	NULL
BJB3LT	NULL
cells	NULL
.	NULL

Steady-state	NULL
levels	NULL
of	NULL
the	NULL
precursor	NULL
p105	NULL
and	NULL
its	NULL
proteolytic	NULL
product	NULL
p50	NULL
are	NULL
higher	NULL
in	NULL
the	NULL
cytosolic	NULL
fraction	NULL
of	NULL
BJB3LT	NULL
cells	NULL
than	NULL
in	NULL
NF-kB	NULL
ACTIVATION	NULL
BY	NULL
LMP-1	NULL
2171	NULL
that	NULL
of	NULL
BJAB	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
p50	NULL
levels	NULL
are	NULL
also	NULL
higher	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
of	NULL
BJB3LT	NULL
cells	NULL
than	NULL
in	NULL
that	NULL
of	NULL
BJAB	NULL
cells	NULL
.	NULL

A	NULL
protein	NULL
migrating	NULL
faster	NULL
than	NULL
p105	NULL
is	NULL
faintly	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
using	NULL
anti-p105	NULL
antibodies	NULL
.	NULL

The	NULL
origin	NULL
of	NULL
this	NULL
protein	NULL
is	NULL
unknown	NULL
,	NULL
although	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
some	NULL
degree	NULL
of	NULL
cytosolic	NULL
contamination	NULL
.	NULL

Results	NULL
to	NULL
those	NULL
similar	NULL
for	NULL
p105	NULL
and	NULL
p50	NULL
were	NULL
obtained	NULL
when	NULL
p100	NULL
and	NULL
p52	NULL
were	NULL
analyzed	NULL
in	NULL
BJB3LT	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
EMSA	NULL
and	NULL
immunoblotting	NULL
experiments	NULL
indicate	NULL
that	NULL
LMP-1-positive	NULL
cells	NULL
contain	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
probably	NULL
secondary	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
IxB	NULL
molecules	NULL
that	NULL
target	NULL
p65/p50	NULL
and	NULL
p65/pS52	NULL
heterodimers	NULL
such	NULL
as	NULL
IkxBa	NULL
and/or	NULL
p105/p100	NULL
.	NULL

Increased	NULL
steady-state	NULL
levels	NULL
of	NULL
p105	NULL
and	NULL
p100	NULL
in	NULL
BJB3LT	NULL
cells	NULL
suggest	NULL
their	NULL
increased	NULL
synthesis	NULL
by	NULL
NF-	NULL
«	NULL
x	NULL
B-dependent	NULL
mechanisms	NULL
,	NULL
since	NULL
both	NULL
molecules	NULL
are	NULL
regulated	NULL
by	NULL
NF-KB	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

IxBa	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
are	NULL
increased	NULL
in	NULL
LMP-1-expressing	NULL
cells	NULL
.	NULL

IxBa	NULL
sequesters	NULL
NF-kB	NULL
by	NULL
masking	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
p65	NULL
(	NULL
5	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Posttranslational	NULL
modifications	NULL
of	NULL
IxBa	NULL
such	NULL
as	NULL
phosphorylation	NULL
and/or	NULL
proteolysis	NULL
result	NULL
in	NULL
NF-kB	NULL
and	NULL
IxBa	NULL
dissociation	NULL
(	NULL
4	NULL
,	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IxBa	NULL
is	NULL
selectively	NULL
modified	NULL
in	NULL
BjB3LT	NULL
cells	NULL
,	NULL
thus	NULL
accounting	NULL
for	NULL
the	NULL
continuous	NULL
NF-kB	NULL
translocation	NULL
induced	NULL
by	NULL
LMP-1	NULL
,	NULL
we	NULL
addressed	NULL
its	NULL
phosphorylation	NULL
state	NULL
and	NULL
proteolytic	NULL
processing	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
IxBa	NULL
phosphorylation	NULL
is	NULL
necessary	NULL
for	NULL
NF-	NULL
«	NULL
xB/IxBa	NULL
dissociation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
IxBa	NULL
phosphorylation	NULL
is	NULL
detected	NULL
prior	NULL
to	NULL
its	NULL
proteolytic	NULL
degradation	NULL
following	NULL
cell	NULL
activation	NULL
by	NULL
``	NULL
punctual	NULL
``	NULL
stimuli	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
LPS	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
)	NULL
(	NULL
4	NULL
,	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unknown	NULL
whether	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
LMP-1	NULL
in	NULL
B	NULL
cells	NULL
results	NULL
in	NULL
persistent	NULL
modifications	NULL
of	NULL
IxBa	NULL
.	NULL

To	NULL
study	NULL
the	NULL
phosphorylation	NULL
characteristics	NULL
of	NULL
in	NULL
LMP-1-positive	NULL
and	NULL
LMP	NULL
cells	NULL
,	NULL
we	NULL
first	NULL
performed	NULL
immunoprecipitation	NULL
experiments	NULL
with	NULL
anti-IkBa	NULL
antibodies	NULL
.	NULL

IxBa	NULL
immunoprecipitated	NULL
from	NULL
LMP-1-positive	NULL
cells	NULL
(	NULL
BJgpt2	NULL
,	NULL
BLgpt1	NULL
,	NULL
and	NULL
BjJB3LT	NULL
)	NULL
contained	NULL
an	NULL
additional	NULL
,	NULL
slower-migrating	NULL
form	NULL
of	NULL
IxBa	NULL
than	NULL
the	NULL
parenteral	NULL
LMP-l-negative	NULL
cells	NULL
(	NULL
BJMTLM	NULL
,	NULL
BL41	NULL
,	NULL
and	NULL
BJAB	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
slower-migrating	NULL
form	NULL
of	NULL
IxBa	NULL
present	NULL
in	NULL
LMP-1-positive	NULL
cells	NULL
is	NULL
phosphorylation	NULL
dependent	NULL
,	NULL
BJB3LT	NULL
and	NULL
the	NULL
control	NULL
BJAB	NULL
cell	NULL
lines	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
*°S	NULL
)	NULL
Jmethi-onine-cysteine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
okadaic	NULL
acid	NULL
,	NULL
a	NULL
phosphatase	NULL
inhibitor	NULL
shown	NULL
to	NULL
sustain	NULL
the	NULL
phosphorylated	NULL
state	NULL
of	NULL
IxBa	NULL
following	NULL
punctual	NULL
stimuli	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
,	NULL
IxBa	NULL
was	NULL
immunoprecipitated	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
containing	NULL
phosphatase	NULL
inhibitors	NULL
and	NULL
competitors	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
CIP	NULL
.	NULL

Results	NULL
from	NULL
these	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
indicate	NULL
that	NULL
increased	NULL
levels	NULL
of	NULL
*°S-IxBa	NULL
are	NULL
present	NULL
in	NULL
BjB3LT	NULL
cells	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
with	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
that	NULL
a	NULL
slower-migrating	NULL
form	NULL
of	NULL
IxBa	NULL
is	NULL
immunoprecipitated	NULL
with	NULL
anti-IxBa	NULL
antibodies	NULL
in	NULL
BJB3LT	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
BJAB	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
slower-migrating	NULL
form	NULL
reverts	NULL
into	NULL
the	NULL
faster-migrating	NULL
complex	NULL
upon	NULL
CIP	NULL
treatment	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
IxBa	NULL
becomes	NULL
phosphorylated	NULL
in	NULL
BJB3LT	NULL
cells	NULL
,	NULL
which	NULL
probably	NULL
renders	NULL
the	NULL
molecule	NULL
susceptible	NULL
to	NULL
subsequent	NULL
proteolysis	NULL
.	NULL

The	NULL
latter	NULL
possibiligy	NULL
is	NULL
partially	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
increased	NULL
levels	NULL
of	NULL
*°S-IxBa	NULL
but	NULL
not	NULL
of	NULL
steady-state	NULL
protein	NULL
are	NULL
observed	NULL
in	NULL
the	NULL
same	NULL
experiment	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
with	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
increased	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
in	NULL
LMP-1-expressing	NULL
cells	NULL
,	NULL
a	NULL
*°S	NULL
pulse-chase	NULL
labeling	NULL
experiment	NULL
was	NULL
performed	NULL
.	NULL

A	NULL
2-h	NULL
pulse	NULL
again	NULL
demonstrates	NULL
higher	NULL
*°S	NULL
levels	NULL
of	NULL
IxBa	NULL
in	NULL
BjB3LT	NULL
cells	NULL
than	NULL
in	NULL
BJAB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Chase	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
cysteine	NULL
and	NULL
methionine	NULL
for	NULL
60	NULL
and	NULL
150	NULL
min	NULL
indicates	NULL
that	NULL
°°S-IxBa	NULL
levels	NULL
decrease	NULL
at	NULL
a	NULL
faster	NULL
rate	NULL
in	NULL
BJB3LT	NULL
cells	NULL
than	NULL
in	NULL
BJAB	NULL
cells	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
with	NULL
2172	NULL
HERRERO	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
BJ	NULL
(	NULL
MT	NULL
)	NULL
]	NULL
BJ-gpt2|BL41	NULL
|BL-gpt1|	NULL
BJAB	NULL
|BiB3LT	NULL
InBloe	NULL
&	NULL
e	NULL
a	NULL
wa	NULL
oo	NULL
UM	NULL
1	NULL
po	NULL
os	NULL
0	NULL
40	NULL
0	NULL
50006	NULL
B	NULL
aes	NULL
IB	NULL
BJAB	NULL
BiB3LT	NULL
BJAB	NULL
BiBSLT	NULL
CIP	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
6	NULL
aem	NULL
..	NULL
din	NULL
two-	NULL
woe	NULL
-	NULL
Aud	NULL
ane	NULL
IcBo	NULL
.	NULL

1	NULL
200	NULL
s	NULL
-	NULL
4	NULL
5	NULL
60007	NULL
8	NULL
C	NULL
BJAB	NULL
BiBgLt	NULL
0	NULL
-	NULL
60	NULL
180	NULL
0	NULL
60°	NULL
150	NULL
mrsm=	NULL
ug	NULL
-	NULL
.	NULL

3G	NULL
|	NULL
a	NULL
€	NULL
3	NULL
IxBo-	NULL
-	NULL
Guam	NULL
wos	NULL
Mitte	NULL
inces	NULL
g	NULL
~	NULL
o	NULL
@	NULL
.2	NULL
102	NULL
s	NULL
4005006	NULL
5	NULL
®	NULL
time	NULL
(	NULL
hours	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

IxBa	NULL
«	NULL
is	NULL
phosphorylated	NULL
and	NULL
its	NULL
synthesis	NULL
and	NULL
proteolysis	NULL
are	NULL
increased	NULL
in	NULL
LMP-1-transfected	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitates	NULL
of	NULL
IxBa	NULL
from	NULL
LMP-1-positive	NULL
cells	NULL
(	NULL
BJgpt2	NULL
,	NULL
BLgpt-1	NULL
,	NULL
and	NULL
BJB3LT	NULL
)	NULL
and	NULL
their	NULL
parental	NULL
control	NULL
cells	NULL
(	NULL
BJMTLM	NULL
,	NULL
BL41	NULL
,	NULL
and	NULL
BJAB	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-IxBa	NULL
antibodies	NULL
,	NULL
using	NULL
ECL	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoprecipitation	NULL
(	NULL
*°8	NULL
)	NULL
of	NULL
IxBa	NULL
from	NULL
[	NULL
*°S	NULL
]	NULL
Met-Cys-labeled	NULL
BJAB	NULL
and	NULL
BJB3LT	NULL
cells	NULL
,	NULL
separation	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transfer	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
,	NULL
and	NULL
autoradiography	NULL
.	NULL

The	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
was	NULL
subsequently	NULL
washed	NULL
and	NULL
immunoblotted	NULL
(	NULL
IB	NULL
)	NULL
with	NULL
anti-IxBa	NULL
antibodies	NULL
and	NULL
detected	NULL
by	NULL
ECL	NULL
.	NULL

(	NULL
C	NULL
)	NULL
BJAB	NULL
and	NULL
BJB3LT	NULL
[	NULL
*S	NULL
)	NULL
Met-Cys-labeled	NULL
cells	NULL
were	NULL
pulsed	NULL
for	NULL
2	NULL
h	NULL
and	NULL
harvested	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
chased	NULL
for	NULL
60	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
and	NULL
150	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
min	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
Met-Cys	NULL
.	NULL

This	NULL
procedure	NULL
was	NULL
followed	NULL
by	NULL
cell	NULL
lysis	NULL
and	NULL
immunoprecipitation	NULL
of	NULL
IxBa	NULL
.	NULL

This	NULL
molecule	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Densitometry	NULL
of	NULL
IxBa	NULL
from	NULL
a	NULL
experiment	NULL
similar	NULL
to	NULL
that	NULL
described	NULL
for	NULL
panel	NULL
B	NULL
,	NULL
using	NULL
an	NULL
AMBIS	NULL
reader	NULL
.	NULL

IxBo	NULL
.	NULL

and	NULL
an	NULL
unrelated	NULL
protein	NULL
were	NULL
scanned	NULL
,	NULL
and	NULL
the	NULL
counts	NULL
per	NULL
minute	NULL
of	NULL
IxBa	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
counts	NULL
per	NULL
minute	NULL
of	NULL
the	NULL
irrelevant	NULL
protein	NULL
per	NULL
lane	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
four	NULL
different	NULL
experiments	NULL
.	NULL

lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
half-lives	NULL
of	NULL
IxBa	NULL
were	NULL
calculated	NULL
to	NULL
be	NULL
70	NULL
and	NULL
100	NULL
min	NULL
for	NULL
BJB3LT	NULL
and	NULL
BJAB	NULL
cells	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
increased	NULL
IxBa	NULL
synthesis	NULL
is	NULL
followed	NULL
by	NULL
increased	NULL
degradation	NULL
(	NULL
probably	NULL
secondary	NULL
to	NULL
a	NULL
qualitative	NULL
phosphorylation	NULL
modification	NULL
)	NULL
in	NULL
LMP-1-positive	NULL
cells	NULL
.	NULL

This	NULL
results	NULL
in	NULL
similar	NULL
steady-state	NULL
levels	NULL
of	NULL
IxBa	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

Increased	NULL
transcriptional	NULL
activity	NULL
of	NULL
p105	NULL
and	NULL
IKBa	NULL
(	NULL
MAD3	NULL
)	NULL
in	NULL
LMP-1-expressing	NULL
cells	NULL
.	NULL

p105	NULL
and	NULL
IxBa	NULL
are	NULL
tran-scriptionally	NULL
regulated	NULL
by	NULL
NF-kB	NULL
(	NULL
22	NULL
,	NULL
40	NULL
)	NULL
.	NULL

This	NULL
mechanism	NULL
compensates	NULL
for	NULL
their	NULL
usage	NULL
during	NULL
the	NULL
activation	NULL
cycle	NULL
of	NULL
NF-kB	NULL
(	NULL
37	NULL
)	NULL
.	NULL

To	NULL
study	NULL
whether	NULL
the	NULL
regulatory	NULL
loop	NULL
between	NULL
NF-kB	NULL
,	NULL
p105	NULL
,	NULL
and	NULL
IxBa	NULL
is	NULL
present	NULL
in	NULL
BJB3LT	NULL
cells	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
these	NULL
and	NULL
control	NULL
cells	NULL
(	NULL
BJAB	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
p105	NULL
and	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
probes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
increased	NULL
steady-state	NULL
levels	NULL
of	NULL
both	NULL
p105	NULL
and	NULL
IxBa	NULL
are	NULL
present	NULL
in	NULL
BJB3LT	NULL
cells	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
increased	NULL
IxBa	NULL
RNA	NULL
level	NULL
is	NULL
secondary	NULL
to	NULL
an	NULL
increased	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
enhancer-promoter	NULL
gene	NULL
,	NULL
transfec-	NULL
J.	NULL
ViroL	NULL
.	NULL

tion	NULL
of	NULL
the	NULL
wild-type	NULL
MAD3	NULL
enhancer-promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
MAD3	NULL
luc	NULL
)	NULL
or	NULL
a	NULL
MAD3	NULL
enhancer-promoter	NULL
luciferase	NULL
gene	NULL
lacking	NULL
the	NULL
NF-kB	NULL
binding	NULL
motif	NULL
was	NULL
performed	NULL
.	NULL

Luciferase	NULL
activity	NULL
of	NULL
MAD3	NULL
luc	NULL
is	NULL
greater	NULL
in	NULL
BJB3LT	NULL
cells	NULL
than	NULL
in	NULL
parental	NULL
BJAB	NULL
cells	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
within	NULL
the	NULL
enhancer	NULL
region	NULL
significantly	NULL
reduces	NULL
the	NULL
luciferase	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
increased	NULL
transcriptional	NULL
activity	NULL
in	NULL
BJ	NULL
[	NULL
B3LT	NULL
cells	NULL
is	NULL
NF-kB	NULL
dependent	NULL
.	NULL

p105	NULL
transcription	NULL
regulation	NULL
is	NULL
also	NULL
NF-kB	NULL
dependent	NULL
(	NULL
40	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
increased	NULL
p105	NULL
protein	NULL
levels	NULL
and	NULL
RNA	NULL
present	NULL
in	NULL
LMP-1-positive	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
p105	NULL
enhancer-promoter	NULL
region	NULL
,	NULL
a	NULL
luciferase	NULL
construct	NULL
containing	NULL
this	NULL
regulatory	NULL
region	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
TK-B-Gal	NULL
reporter	NULL
gene	NULL
into	NULL
BJAB	NULL
and	NULL
BjB3LT	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
promoter-enhancer	NULL
region	NULL
of	NULL
p105	NULL
is	NULL
also	NULL
upregulated	NULL
in	NULL
the	NULL
LMP-1-positive	NULL
cells	NULL
,	NULL
BjB3LT	NULL
.	NULL

Because	NULL
both	NULL
p105	NULL
and	NULL
the	NULL
related	NULL
protein	NULL
p100	NULL
have	NULL
IxB-like	NULL
functions	NULL
and	NULL
when	NULL
processed	NULL
by	NULL
proteolytic	NULL
mechanisms	NULL
yield	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
respectively	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
this	NULL
processing	NULL
was	NULL
increased	NULL
in	NULL
LMP	NULL
-1-positive	NULL
cells	NULL
.	NULL

In	NULL
pulse-chase	NULL
methionine-cysteine	NULL
labeling	NULL
experiments	NULL
followed	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
p105/p50	NULL
and	NULL
p100/p52	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
the	NULL
half-lives	NULL
of	NULL
both	NULL
precursors	NULL
and	NULL
the	NULL
proteolytic	NULL
processing	NULL
into	NULL
p50	NULL
and	NULL
p52	NULL
were	NULL
the	NULL
same	NULL
in	NULL
LMP-1-positive	NULL
and	NULL
control	NULL
(	NULL
LMP-1-negative	NULL
)	NULL
cells	NULL
despite	NULL
increased	NULL
synthesis	NULL
of	NULL
both	NULL
p105	NULL
and	NULL
p100	NULL
in	NULL
LMP-l-positive	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
LMP-1	NULL
activates	NULL
NF-kB	NULL
at	NULL
least	NULL
by	NULL
inducing	NULL
posttranslational	NULL
modifications	NULL
of	NULL
IxBa	NULL
.	NULL

This	NULL
results	NULL
in	NULL
a	NULL
regulatory	NULL
loop	NULL
that	NULL
involves	NULL
increased	NULL
NF-kB	NULL
translocation	NULL
,	NULL
which	NULL
results	NULL
in	NULL
increased	NULL
synthesis	NULL
of	NULL
p105	NULL
,	NULL
p100	NULL
,	NULL
and	NULL
IxBa	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
continuous	NULL
utilization	NULL
of	NULL
this	NULL
relevant	NULL
transcription	NULL
factor	NULL
and	NULL
its	NULL
inhibitory	NULL
molecule	NULL
.	NULL

DISCUSSION	NULL
Although	NULL
the	NULL
EBV	NULL
LMP-1	NULL
protein	NULL
is	NULL
sufficient	NULL
for	NULL
cell	NULL
transformation	NULL
(	NULL
19	NULL
,	NULL
41	NULL
)	NULL
,	NULL
the	NULL
exact	NULL
mechanisms	NULL
regulating	NULL
virus-induced	NULL
oncogenesis	NULL
remain	NULL
incompletely	NULL
characterized	NULL
.	NULL

Viral	NULL
proteins	NULL
with	NULL
oncogenic	NULL
capabilities	NULL
other	NULL
than	NULL
LMP-1	NULL
such	NULL
as	NULL
hepatitis	NULL
B	NULL
virus	NULL
HBx	NULL
protein	NULL
and	NULL
HTLV-I	NULL
Tax	NULL
also	NULL
result	NULL
in	NULL
NF-kB	NULL
activation	NULL
(	NULL
13	NULL
,	NULL
16	NULL
,	NULL
18	NULL
,	NULL
21	NULL
,	NULL
27	NULL
,	NULL
34	NULL
,	NULL
38	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
biochemical	NULL
and	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
LMP-1	NULL
activates	NULL
NF-kB	NULL
.	NULL

These	NULL
results	NULL
will	NULL
aide	NULL
future	NULL
investigations	NULL
to	NULL
establish	NULL
the	NULL
role	NULL
of	NULL
NF-kB	NULL
in	NULL
LMP-1-mediated	NULL
oncogenesis	NULL
and	NULL
activation	NULL
of	NULL
lymphoid	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
growth	NULL
regulation	NULL
.	NULL

Although	NULL
a	NULL
large	NULL
body	NULL
of	NULL
information	NULL
is	NULL
now	NULL
available	NULL
as	NULL
to	NULL
how	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
related	NULL
proteins	NULL
interact	NULL
with	NULL
their	NULL
respective	NULL
IxB	NULL
molecules	NULL
,	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
in	NULL
B	NULL
lymphocytes	NULL
remain	NULL
relatively	NULL
unex-plored	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
by	NULL
LMP-1	NULL
to	NULL
result	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
we	NULL
first	NULL
addressed	NULL
which	NULL
Rel/NF-	NULL
«	NULL
B	NULL
molecules	NULL
and	NULL
IxBs	NULL
were	NULL
selectively	NULL
modified	NULL
by	NULL
LMP-1	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
specific	NULL
IxB	NULL
as	NULL
responsible	NULL
for	NULL
LMP-1-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
would	NULL
provide	NULL
a	NULL
readout	NULL
for	NULL
studying	NULL
upstream	NULL
pathways	NULL
leading	NULL
to	NULL
modification	NULL
of	NULL
such	NULL
IxBs	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
LMP-1	NULL
results	NULL
in	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
p65	NULL
in	NULL
conjunction	NULL
with	NULL
p50	NULL
and	NULL
p52	NULL
.	NULL

Because	NULL
c-Rel	NULL
was	NULL
found	NULL
to	NULL
be	NULL
present	NULL
at	NULL
equal	NULL
levels	NULL
in	NULL
both	NULL
LMP-1-negative	NULL
and	NULL
LMP-1-positive	NULL
B-cell	NULL
lines	NULL
,	NULL
it	NULL
was	NULL
inferred	NULL
that	NULL
this	NULL
protein	NULL
and	NULL
its	NULL
inhibitor	NULL
molecule	NULL
(	NULL
IxBB	NULL
?	NULL
)	NULL

were	NULL
not	NULL
targets	NULL
of	NULL
LMP-1	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
studies	NULL
focused	NULL
on	NULL
IxB	NULL
molecules	NULL
that	NULL
regulate	NULL
p65	NULL
such	NULL
as	NULL
IxBa	NULL
and	NULL
the	NULL
precursor	NULL
molecules	NULL
p100	NULL
and	NULL
p105	NULL
.	NULL

Results	NULL
from	NULL
such	NULL
studies	NULL
indicate	NULL
that	NULL
IxBa	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
NF-kB	NULL
ACTIVATION	NULL
BY	NULL
LMP-1	NULL
2173	NULL
B	NULL
A	NULL
260	NULL
250	NULL
a	NULL
G	NULL
]	NULL
--	NULL
3	NULL
|	NULL
a	NULL
$	NULL
a	NULL
$	NULL
1	NULL
,	NULL
6	NULL
p105-	NULL
t	NULL
‘	NULL
v	NULL
S	NULL
240	NULL
8	NULL
iso	NULL
?	NULL

€	NULL
&	NULL
2	NULL
MADs	NULL
-	NULL
ﬂ	NULL
3	NULL
f	NULL
m	NULL
8	NULL
120	NULL
©	NULL
j	NULL
@	NULL
3	NULL
‘	NULL
5	NULL
3	NULL
-	NULL
50-4	NULL
GAPDH	NULL
-	NULL
-	NULL
.	NULL

awaneme	NULL
3	NULL
p	NULL
_C	NULL
k-	NULL
[	NULL
-	NULL
_	NULL
,	NULL
o	NULL
o	NULL
,	NULL
kB-luc	NULL
a	NULL
|-	NULL
l	NULL
-	NULL
fa	NULL
]	NULL
-	NULL
|	NULL
-	NULL
p105-luc	NULL
MAD3-luc	NULL
-	NULL
|T	NULL
]	NULL
-|-	NULL
|	NULL
+	NULL
]	NULL
-	NULL
BJAB	NULL
-	NULL
BiB3LT	NULL
MADB3DKB-luc	NULL
-	NULL
-	NULL
+	NULL
|	NULL
-	NULL
-	NULL
|	NULL
+	NULL
BJAB	NULL
BiB3LT	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Increased	NULL
transcription	NULL
of	NULL
IxBe	NULL
(	NULL
MAD3	NULL
)	NULL
and	NULL
p105	NULL
in	NULL
BJB3LT	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
BJAB	NULL
and	NULL
BJB3LT	NULL
cells	NULL
.	NULL

The	NULL
probe	NULL
is	NULL
marked	NULL
at	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfection	NULL
of	NULL
MAD3-c-luc	NULL
,	NULL
MAD3	NULL
A	NULL
«	NULL
B-c-lue	NULL
,	NULL
and	NULL
p105	NULL
luc	NULL
into	NULL
10	NULL
``	NULL
BJAB	NULL
and	NULL
BjB3LT	NULL
cells	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
luciferase	NULL
units	NULL
normalized	NULL
to	NULL
B-Gal	NULL
units	NULL
.	NULL

but	NULL
not	NULL
p100	NULL
or	NULL
p105	NULL
was	NULL
selectively	NULL
modified	NULL
by	NULL
LMP-1	NULL
.	NULL

Although	NULL
little	NULL
information	NULL
is	NULL
available	NULL
as	NULL
to	NULL
how	NULL
a	NULL
chronic	NULL
stim-ulus	NULL
,	NULL
such	NULL
as	NULL
persistent	NULL
expression	NULL
of	NULL
LMP-1	NULL
,	NULL
may	NULL
modify	NULL
IxBa	NULL
to	NULL
result	NULL
in	NULL
continuous	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
LMP-1	NULL
causes	NULL
continuous	NULL
modifications	NULL
of	NULL
IxBa	NULL
by	NULL
at	NULL
least	NULL
two	NULL
mechanisms	NULL
:	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
.	NULL

These	NULL
two	NULL
events	NULL
resemble	NULL
IxBa	NULL
modifications	NULL
induced	NULL
by	NULL
punctual	NULL
stimuli	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
or	NULL
LPS	NULL
.	NULL

Similar	NULL
data	NULL
have	NULL
recently	NULL
been	NULL
reported	NULL
for	NULL
a	NULL
model	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
unknown	NULL
whether	NULL
IxBa	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
is	NULL
the	NULL
triggering	NULL
event	NULL
resulting	NULL
in	NULL
its	NULL
subsequent	NULL
degradation	NULL
,	NULL
data	NULL
generated	NULL
from	NULL
other	NULL
cell	NULL
models	NULL
indicate	NULL
that	NULL
IxBa	NULL
phosphorylation	NULL
precedes	NULL
and	NULL
is	NULL
required	NULL
for	NULL
proteolysis	NULL
,	NULL
even	NULL
though	NULL
the	NULL
latter	NULL
event	NULL
ultimately	NULL
causes	NULL
NF-kB	NULL
release	NULL
(	NULL
352	NULL
)	NULL
.	NULL

Studies	NULL
are	NULL
currently	NULL
under	NULL
way	NULL
to	NULL
test	NULL
this	NULL
sequential	NULL
mechanism	NULL
in	NULL
LMP-1-positive	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
identification	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
mediated	NULL
by	NULL
LMP-1	NULL
as	NULL
a	NULL
key	NULL
event	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
regulation	NULL
is	NULL
a	NULL
first	NULL
step	NULL
in	NULL
identifying	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
triggered	NULL
by	NULL
LMP-1	NULL
and	NULL
provides	NULL
a	NULL
first	NULL
example	NULL
of	NULL
how	NULL
a	NULL
viral	NULL
protein	NULL
may	NULL
result	NULL
in	NULL
continuous	NULL
modification	NULL
of	NULL
IxBa	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
phosphorylated	NULL
IxBa	NULL
becomes	NULL
susceptible	NULL
to	NULL
degradation	NULL
,	NULL
which	NULL
would	NULL
explain	NULL
the	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
observed	NULL
in	NULL
our	NULL
model	NULL
.	NULL

The	NULL
B	NULL
lymphocyte	NULL
,	NULL
in	NULL
order	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
shorter	NULL
half-life	NULL
of	NULL
IxBa	NULL
,	NULL
uses	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
regulatory	NULL
loop	NULL
to	NULL
increase	NULL
IxBa	NULL
transcription	NULL
and	NULL
synthesis	NULL
;	NULL
this	NULL
ultimately	NULL
results	NULL
in	NULL
a	NULL
balanced	NULL
steady-state	NULL
level	NULL
of	NULL
IxBa	NULL
protein	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
this	NULL
situation	NULL
is	NULL
not	NULL
observed	NULL
in	NULL
another	NULL
model	NULL
of	NULL
chronic	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
such	NULL
as	NULL
that	NULL
of	NULL
persistent	NULL
HIV	NULL
infection	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
:	NULL
IxBa	NULL
is	NULL
selectively	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
by	NULL
HIV	NULL
,	NULL
but	NULL
the	NULL
monocytic	NULL
cell	NULL
is	NULL
unable	NULL
to	NULL
completely	NULL
compensate	NULL
for	NULL
IxBa	NULL
utilization	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
decreased	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
IxBa	NULL
(	NULL
28a	NULL
)	NULL
.	NULL

For	NULL
the	NULL
reasons	NULL
cited	NULL
above	NULL
,	NULL
LMP-1	NULL
expressing	NULL
B-lymphocyte	NULL
cell	NULL
lines	NULL
provide	NULL
a	NULL
useful	NULL
model	NULL
for	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
kinase/phosphate	NULL
and	NULL
protease	NULL
(	NULL
s	NULL
)	NULL
that	NULL
regulate	NULL
IxBa	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Even	NULL
though	NULL
a	NULL
large	NULL
body	NULL
of	NULL
results	NULL
was	NULL
obtained	NULL
for	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
LMP-1	NULL
,	NULL
many	NULL
of	NULL
the	NULL
observations	NULL
have	NULL
also	NULL
been	NULL
confirmed	NULL
by	NULL
transient	NULL
expression	NULL
of	NULL
LMP-1	NULL
.	NULL

This	NULL
fact	NULL
,	NULL
together	NULL
with	NULL
recent	NULL
published	NULL
reports	NULL
in	NULL
which	NULL
multiple	NULL
cell	NULL
lines	NULL
were	NULL
tested	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
LMP	NULL
-1	NULL
to	NULL
activate	NULL
NF-kB	NULL
(	NULL
34	NULL
)	NULL
,	NULL
strengthens	NULL
the	NULL
conclusion	NULL
that	NULL
LMP-1	NULL
activates	NULL
NF-kB	NULL
and	NULL
it	NULL
is	NULL
not	NULL
due	NULL
to	NULL
an	NULL
artifact	NULL
derived	NULL
from	NULL
studying	NULL
a	NULL
specific	NULL
cloned	NULL
cell	NULL
line	NULL
in	NULL
which	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
a	NULL
function	NULL
not	NULL
of	NULL
LMP-1	NULL
but	NULL
of	NULL
intrinsic	NULL
differences	NULL
within	NULL
such	NULL
clone	NULL
.	NULL

Although	NULL
our	NULL
results	NULL
have	NULL
identified	NULL
IxBa	NULL
as	NULL
a	NULL
target	NULL
of	NULL
LMP-1	NULL
,	NULL
other	NULL
IxB	NULL
molecules	NULL
such	NULL
as	NULL
p105	NULL
and	NULL
p100	NULL
that	NULL
also	NULL
regulate	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
could	NULL
have	NULL
also	NULL
been	NULL
selectively	NULL
modified	NULL
in	NULL
LMP-1-expressing	NULL
cells	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
even	NULL
though	NULL
p105	NULL
and	NULL
p100	NULL
are	NULL
indirectly	NULL
regulated	NULL
by	NULL
LMP	NULL
-1	NULL
via	NULL
NF-kB	NULL
(	NULL
increased	NULL
steady-state	NULL
protein	NULL
levels	NULL
secondary	NULL
to	NULL
increased	NULL
gene	NULL
transcription	NULL
)	NULL
,	NULL
they	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
modified	NULL
in	NULL
a	NULL
way	NULL
that	NULL
results	NULL
in	NULL
enhanced	NULL
NF-kB	NULL
translocation	NULL
.	NULL

The	NULL
increased	NULL
steady-state	NULL
levels	NULL
of	NULL
both	NULL
p105	NULL
and	NULL
p100	NULL
in	NULL
LMP-1-expressing	NULL
B	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
secondary	NULL
to	NULL
increased	NULL
synthesis	NULL
and	NULL
to	NULL
an	NULL
increased	NULL
rate	NULL
proteolysis	NULL
into	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
which	NULL
are	NULL
similar	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

Even	NULL
though	NULL
it	NULL
is	NULL
unclear	NULL
what	NULL
direct	NULL
impact	NULL
LMP-1-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
has	NULL
in	NULL
virus-induced	NULL
oncogenesis	NULL
,	NULL
identification	NULL
of	NULL
IxBa	NULL
as	NULL
a	NULL
target	NULL
of	NULL
LMP-1	NULL
provides	NULL
a	NULL
foundation	NULL
for	NULL
investigating	NULL
pathways	NULL
upstream	NULL
of	NULL
IxBa	NULL
that	NULL
may	NULL
be	NULL
activated	NULL
by	NULL
LMP-1	NULL
.	NULL

Because	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
early	NULL
event	NULL
triggered	NULL
by	NULL
LMP-1	NULL
,	NULL
this	NULL
model	NULL
will	NULL
potentially	NULL
be	NULL
useful	NULL
for	NULL
studying	NULL
proximal	NULL
second	NULL
messenger-signal	NULL
transduction	NULL
pathways	NULL
that	NULL
can	NULL
mediate	NULL
LMP-1-induced	NULL
oncogenesis	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Douglas	NULL
Hauschild	NULL
for	NULL
excellent	NULL
secretarial	NULL
assistance	NULL
and	NULL
Steve	NULL
Ziesmer	NULL
for	NULL
help	NULL
in	NULL
performing	NULL
LMP-1	NULL
staining	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
NIH	NULL
grant	NULL
RO1	NULL
AI36076-01	NULL
,	NULL
the	NULL
Eagles	NULL
Cancer	NULL
Fund	NULL
,	NULL
and	NULL
the	NULL
Mayo	NULL
Foundation	NULL
.	NULL

J.A.H	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
FIS	NULL
scholarship	NULL
from	NULL
the	NULL
Spanish	NULL
government	NULL
,	NULL
and	NULL
C.V.P	NULL
.	NULL

is	NULL
an	NULL
American	NULL
Foundation	NULL
for	NULL
AIDS	NULL
Research	NULL
scholar	NULL
.	NULL

2174	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

HERRERO	NULL
ET	NULL
AL	NULL
.	NULL

REFERENCES	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913.	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-kB	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB-e.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536.	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
Donald	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysac-	NULL
charide	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAD3	NULL
and	NULL
activation	NULL
of	NULL
c-rel	NULL
and	NULL
related	NULL
NF-kB	NULL
proteins	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:11803-11810.	NULL
.	NULL

Cuomo	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Trivedi	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
G.	NULL
Winberg	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Masucci	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-encoded	NULL
membrane	NULL
antigen	NULL
(	NULL
LMP	NULL
)	NULL
increases	NULL
the	NULL
stimulatory	NULL
capacity	NULL
of	NULL
EBV-negative	NULL
B	NULL
lymphoma	NULL
lines	NULL
in	NULL
allogeneic	NULL
mixed	NULL
lymphocyte	NULL
cultures	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:2293.	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcrip-	NULL
tion	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Finke	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Fritzen	NULL
,	NULL
P.	NULL
Ternes	NULL
,	NULL
P.	NULL
Trivedi	NULL
,	NULL
K.	NULL
J.	NULL
Bross	NULL
,	NULL
W.	NULL
Lange	NULL
,	NULL
R.	NULL
Mertelsmann	NULL
,	NULL
and	NULL
G.	NULL
Dolken	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
bel-2	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
:	NULL
induction	NULL
by	NULL
latent	NULL
Epstein-Barr	NULL
virus	NULL
genes	NULL
.	NULL

Blood	NULL
80	NULL
:	NULL
459-469	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

I	NULL
«	NULL
B/	NULL
MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transactivation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
.	NULL

3:1339-1352	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
viro	NULL
of	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Hammarskjold	NULL
,	NULL
M.-L.	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Simurda	NULL
.	NULL

1992	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
transactivates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
through	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

340:6496-6501	NULL
.	NULL

Henderson	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
R.	NULL
Long-necker	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A.	NULL
Rickinson	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
bel-2	NULL
expression	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
protects	NULL
infected	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
65:1107-1115	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Krinke	NULL
,	NULL
Y.	NULL
Ben-Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxB-a	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
ankyrin	NULL
motifs	NULL
of	NULL
inhibitory	NULL
factor	NULL
kappa	NULL
B	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3584-3588	NULL
.	NULL

Joske	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
H.	NULL
Knecht	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
in	NULL
lymphomas	NULL
:	NULL
a	NULL
review	NULL
.	NULL

Blood	NULL
Rev	NULL
.	NULL

7:215-222	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tex-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6443-6451	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9150-9154	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Laherty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
H.	NULL
M.	NULL
Hu	NULL
,	NULL
A.	NULL
W.	NULL
Opipari	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
product	NULL
induces	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
expression	NULL
by	NULL
activating	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24157-24160	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
re/NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043-5049	NULL
.	NULL

Lewis	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
J.	NULL
McClure	NULL
,	NULL
B.	NULL
Rup	NULL
,	NULL
D.	NULL
W.	NULL
Niesel	NULL
,	NULL
R.	NULL
F.	NULL
Garry	NULL
,	NULL
J.	NULL
D.	NULL
Hoelzer	NULL
,	NULL
24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

K.	NULL
Nazerian	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1981	NULL
.	NULL

Avian	NULL
reticuloendotheliosis	NULL
virus	NULL
:	NULL
identification	NULL
of	NULL
the	NULL
hematopoictic	NULL
target	NULL
cell	NULL
for	NULL
transformation	NULL
.	NULL

Cell	NULL
25	NULL
:	NULL
421-431	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Kopan	NULL
,	NULL
E.	NULL
Fuchs	NULL
,	NULL
J	NULL
.	NULL

Sample	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
Epstcin-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
associates	NULL
with	NULL
vimentin	NULL
in	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:2299-2308.	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Mannick	NULL
,	NULL
K.	NULL
Takada	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1992	NULL
.	NULL

Phenotypes	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
deletion	NULL
mutants	NULL
indicate	NULL
transmembrane	NULL
and	NULL
amino-terminal	NULL
cytoplasmic	NULL
domains	NULL
necessary	NULL
for	NULL
effects	NULL
in	NULL
B-lymphoma	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4612-4616	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Wang	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1986	NULL
.	NULL

Orientation	NULL
and	NULL
patching	NULL
of	NULL
the	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

58:233-237	NULL
.	NULL

Lucito	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Schneider	NULL
.	NULL

1992	NULL
.	NULL

Hepatitis	NULL
B	NULL
virus	NULL
X	NULL
protein	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
without	NULL
a	NULL
requirement	NULL
for	NULL
protein	NULL
kinase	NULL
C.	NULL
J.	NULL
Virol	NULL
.	NULL

66:983-991	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
D.	NULL
Veis	NULL
,	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

Latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
induces	NULL
cellular	NULL
phenotypes	NULL
independently	NULL
of	NULL
expression	NULL
of	NULL
Bel-2	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5269-5278	NULL
.	NULL

28a.McElhinney	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
S.	NULL
MacMorran	NULL
,	NULL
G.	NULL
D.	NULL
Bren	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
and	NULL
29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

C.	NULL
V.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
in	NULL
monocytes	NULL
and	NULL
macro-phages	NULL
persistently	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1500-1509	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1993	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
MAD3	NULL
(	NULL
IxBa	NULL
)	NULL
and	NULL
enhanced	NULL
processing	NULL
of	NULL
the	NULL
NF-xB	NULL
precursor	NULL
p105	NULL
are	NULL
obligatory	NULL
steps	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5059-5066	NULL
.	NULL

Nalesnik	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

Lymphoproliferative	NULL
disease	NULL
in	NULL
organ	NULL
transplant	NULL
re-cipients	NULL
.	NULL

Semin	NULL
.	NULL

Immunopathol	NULL
.	NULL

13:199-216	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
inhibitory	NULL
ankyrin	NULL
and	NULL
activator	NULL
rel	NULL
proteins	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2211-220	NULL
.	NULL

Petti	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
DiMaio	NULL
,	NULL
.	NULL

1994	NULL
.	NULL

Specific	NULL
interaction	NULL
between	NULL
the	NULL
bovine	NULL
papillomavirus	NULL
E5	NULL
transforming	NULL
protein	NULL
and	NULL
the	NULL
beta	NULL
receptor	NULL
for	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
in	NULL
stably	NULL
transformed	NULL
and	NULL
acutely	NULL
transfected	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3582-3592	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Ernst	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IxBa	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4685-4695	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Peng-Pilon	NULL
,	NULL
D.	NULL
S.	NULL
Huen	NULL
,	NULL
R.	NULL
Hardy	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
E.	NULL
Lundgren	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1994	NULL
.	NULL

Upregulation	NULL
of	NULL
be/-2	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
LMP1	NULL
:	NULL
a	NULL
B-cell-specific	NULL
response	NULL
that	NULL
is	NULL
delayed	NULL
relative	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
to	NULL
induction	NULL
of	NULL
cell	NULL
surface	NULL
mark-ers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:5602-5612	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-xB	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p63	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

35a.Steffan	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
C.	NULL
Paya	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

Straus	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
J.	NULL
I	NULL
Cohen	NULL
,	NULL
G.	NULL
Tosato	NULL
,	NULL
and	NULL
J.	NULL
Meier	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
infections	NULL
:	NULL
biology	NULL
,	NULL
pathogenesis	NULL
,	NULL
and	NULL
management	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

118	NULL
:	NULL
45-58	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
involves	NULL
phosphorylation	NULL
to	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
c-ref	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Sun	NULL
,	NULL
S-C	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-xB	NULL
transactivator	NULL
RelA	NULL
(	NULL
p63	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1346-1350	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
N.	NULL
Israél	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:195-203	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1985	NULL
.	NULL

An	NULL
EBV	NULL
membrane	NULL
protein	NULL
expressed	NULL
in	NULL
immortalized	NULL
lymphocytes	NULL
transforms	NULL
established	NULL
rodent	NULL
cells	NULL
.	NULL

Cell	NULL
43:831-840	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
C.	NULL
Sample	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2309-2318	NULL
.	NULL

Young	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1992	NULL
.	NULL

Epstcin-Barr	NULL
virus	NULL
,	NULL
lymphomas	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

3:273-284	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

Purificd	NULL
human	NULL
IxB	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
NF-B	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61:255-265	NULL
.	NULL

